Azathioprine Tablet
Description
ROOTOPTIN-25
Azathioprine 25 mg Tablets
Division: DIABGLYM
Composition
Each tablet contains:
Azathioprine IP — 25 mg
Excipients — q.s.
Colour: Approved colour used
Dosage form: Oral tablet
Product Description
ROOTOPTIN-25 contains Azathioprine 25 mg, an immunosuppressive and immunomodulatory medication formulated for the management of autoimmune disorders, inflammatory diseases, and prevention of organ transplant rejection. Azathioprine is a purine analog that suppresses abnormal immune responses by inhibiting lymphocyte proliferation and reducing immune-mediated tissue damage.
Azathioprine is widely prescribed in rheumatology, nephrology, gastroenterology, dermatology, and transplant medicine for long-term immune modulation. It is particularly beneficial in conditions where excessive immune activation contributes to chronic inflammation and progressive organ damage.
ROOTOPTIN-25 helps maintain disease remission, reduce autoimmune activity, minimize corticosteroid requirements, and support long-term management of chronic immune-mediated disorders under specialist supervision.
Technical Knowledge of Azathioprine
Azathioprine is a prodrug that is converted into 6-mercaptopurine and active thioguanine nucleotides, which inhibit purine synthesis and DNA replication. This selectively suppresses rapidly proliferating immune cells, particularly T and B lymphocytes, resulting in reduced antibody production, decreased cell-mediated immune responses, and attenuation of chronic inflammatory processes.
Because Azathioprine affects immune cell proliferation, therapeutic response may take several weeks to develop, making it suitable for long-term maintenance therapy rather than immediate symptom control.
Mechanism of Action
Azathioprine inhibits purine nucleotide synthesis, suppresses T-lymphocyte and B-lymphocyte proliferation, reduces antibody formation, decreases cell-mediated immune responses, and helps control chronic autoimmune and inflammatory activity.
Key Benefits
Effective immunosuppressive therapy
Helps maintain remission in autoimmune diseases
Reduces immune-mediated inflammation
Supports long-term disease control
May reduce corticosteroid requirements
Helps prevent organ transplant rejection
Suitable for chronic immune modulation under medical supervision
Clinical Applications
ROOTOPTIN-25 is commonly prescribed for rheumatoid arthritis, systemic lupus erythematosus, autoimmune hepatitis, inflammatory bowel disease including ulcerative colitis and Crohn’s disease, nephrotic syndrome, vasculitis, dermatological autoimmune disorders, and prevention of organ transplant rejection.
Facts About Azathioprine
Azathioprine has been extensively used worldwide for autoimmune and transplant indications. It is considered an important steroid-sparing immunosuppressive agent and is widely recommended in multiple clinical guidelines for long-term management of autoimmune disorders. Regular monitoring of complete blood counts and liver function tests is recommended during therapy to ensure safety and optimize treatment outcomes.
Key Facts
Purine analog immunosuppressive agent
Azathioprine 25 mg for long-term immune modulation
Effective in autoimmune and inflammatory disorders
Supports maintenance therapy and disease remission
Widely used in rheumatology, nephrology, gastroenterology, and transplant medicine
Quality-assured pharmaceutical formulation
PCD Pharma Franchise Opportunity
ROOTOPTIN-25 is an excellent product for PCD Pharma Franchise, Specialty Pharma Franchise, and Immunology Franchise across India. The increasing prevalence of autoimmune disorders, inflammatory diseases, and organ transplant care creates strong prescription demand and long-term market potential for this formulation.
Why Choose ROOTOPTIN-25 for PCD Pharma Franchise?
High prescription potential
Strong physician and specialist acceptance
Attractive monopoly franchise opportunity
Competitive pricing
Promotional support available
Visual aids and marketing inputs
Consistent product quality
Excellent repeat business potential
Third Party Manufacturing
Chemsroot Pharmaceutical offers Third Party Manufacturing of Azathioprine 25 mg Tablets with complete manufacturing support for pharmaceutical companies, marketers, exporters, and franchise businesses.
Our Third Party Manufacturing Services Include
Private label manufacturing
Contract manufacturing
Custom brand manufacturing
Loan license manufacturing
DCGI-compliant production
GMP-certified manufacturing
Batch manufacturing documentation
Product registration support
Customized packaging and artwork
Monopoly franchise packaging
Bulk manufacturing capability
Manufacturing Features
Pharmaceutical-grade raw materials
IP/BP/USP quality standards
In-process quality control
Finished product testing
Stability-oriented formulation
Moisture-controlled tablet manufacturing
Blister and Alu-Alu packaging options
ROOTOPTIN-25 from DIABGLYM combines effective immunosuppressive therapy, long-term autoimmune disease management, evidence-based clinical efficacy, and high-quality pharmaceutical manufacturing, making it an ideal product for physicians, rheumatologists, nephrologists, gastroenterologists, dermatologists, PCD Pharma Franchise partners, and Third Party Manufacturing clients seeking a reliable Azathioprine formulation.
